Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study.
Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study.
复制标题
DOI:
10.1186/s12906-017-1630-6
复制
发表时间:
2017-05-19
影响因子:
--
通讯作者:
Zeng-Treitler Q
中科院分区:
文献类型:
--
作者:
Christensen CM;Morris RS;Kapsandoy SC;Archer M;Kuang J;Shane-McWhorter L;Bray BE;Zeng-Treitler Q
While complementary and alternative medicine (CAM) is commonly used in the United States and elsewhere, and hazardous interactions with prescription drugs can occur, patients do not regularly communicate with physicians about their CAM use. The objective of this study was to discover patient information needs and preferences for herb-drug-disease interaction alerts. We recruited 50 people from several locations within the University of Utah Hospital to participate in this structured interview study. They were asked to provide their preferences for the herb-drug-disease interaction alerts. Qualitative methods were used to reveal the themes that emerged from the interviews. Most participants reported they had previously used, or they were currently using, CAM therapies. The majority had made the effort to inform their healthcare provider(s) about their CAM usage, although some had not. We found that most respondents were interested in receiving alerts and information about potential interactions. Many preferred to receive the alerts in a variety of ways, both in person and electronically. In addition to conventional medicine, many patients regularly use complementary and alternative therapies. And yet, communication between patients and providers about CAM use is not consistent. There is a demand for interventions in health care that provide timely, integrative communication support. Delivering the herb-drug-disease alerts through multiple channels could help meet critical patient information needs. The online version of this article (doi:10.1186/s12906-017-1630-6) contains supplementary material, which is available to authorized users.